| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MacRogenics Inc (MGNX) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. MGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 152.2K | $697.2K | - | |
| Dir | 111.0K | $508.4K | - | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - | |
| VP | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2016 | Cilinski Lynn | VP, Controller And Treasurer | Sale+OE | 8,922 | $27.22 | $242,856.84 | -82.3% | |
| May 27, 2016 | Cilinski Lynn | VP, Controller And Treasurer | Sale+OE | 5,000 | $25.00 | $125,000.00 | -72.2% | |
| Mar 3, 2016 | Costa Paulo F | Director | Buy | 10,000 | $17.20 | $172,000.00 | +20.2% | |
| Jan 4, 2016 | Wigginton Jon Marc | Sr VP, Clinical | Sale+OE | 10,000 | $29.64 | $296,400.00 | -100% | |
| Nov 23, 2015 | Cilinski Lynn | VP, Controller And Treasurer | Sale+OE | 6,921 | $35.00 | $242,235.00 | -41.9% | |
| Nov 16, 2015 | Bonvini Ezio72 | Senior VP, Research | Sell | 3,117 | $31.44 | $97,998.48 | -4.2% | |
| Oct 15, 2015 | Bonvini Ezio72 | Senior VP, Research | Sell | 6,233 | $25.21 | $157,133.93 | -7.8% | |
| Oct 1, 2015 | Wigginton Jon Marc | Sr VP, Clinical | Sale+OE | 5,000 | $21.11 | $105,550.00 | -100% | |
| Aug 3, 2015 | Wigginton Jon Marc | Sr VP, Clinical | Sale+OE | 10,000 | $37.15 | $371,500.00 | -100% | |
| Jul 10, 2015 | Bonvini Ezio72 | Senior VP, Research | Sale+OE | 2,400 | $38.09 | $91,416.00 | -6.1% |